138 related articles for article (PubMed ID: 3007684)
1. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
[TBL] [Abstract][Full Text] [Related]
2. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
[TBL] [Abstract][Full Text] [Related]
3. Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC).
Cerny T; Pedrazzini A; Joss RA; Brunner KW
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1791-4. PubMed ID: 2850194
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of teniposide in small cell carcinoma of the lung.
Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
[TBL] [Abstract][Full Text] [Related]
5. Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
Grozea PN; Crowley JJ; Canfield VA; Kingsbury L; Ross SW; Beltran GS; Laufman LR; Weiss GR; Livingston RB
Cancer; 1997 Sep; 80(6):1029-33. PubMed ID: 9305702
[TBL] [Abstract][Full Text] [Related]
6. Teniposide in the treatment of non-small cell lung carcinoma.
Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
[TBL] [Abstract][Full Text] [Related]
7. Teniposide (VM26) as second-line treatment for small cell lung cancer.
Tummarello D; Guidi F; Torresi U; Dazzi C; Cellerino R
Anticancer Res; 1990; 10(2A):397-9. PubMed ID: 2161198
[TBL] [Abstract][Full Text] [Related]
8. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
[TBL] [Abstract][Full Text] [Related]
9. High-dose teniposide for refractory malignancies: a phase I study.
de Vries EG; Mulder NH; Postmus PE; Vriesendorp R; Willemse PH; Sleijfer DT
Cancer Treat Rep; 1986 May; 70(5):595-8. PubMed ID: 3708608
[TBL] [Abstract][Full Text] [Related]
10. Teniposide in the treatment of small cell lung cancer: a review.
Hansen HH; Dombernowsky P; Hansen M; Bork E
Semin Oncol; 1992 Apr; 19(2 Suppl 6):65-8. PubMed ID: 1329227
[TBL] [Abstract][Full Text] [Related]
11. Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.
Bork E; Ersbøll J; Dombernowsky P; Bergman B; Hansen M; Hansen HH
J Clin Oncol; 1991 Sep; 9(9):1627-31. PubMed ID: 1651994
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Tirelli U; Carbone A; Crivellari D; Volpe R; Franchin G; Veronesi A; Galligioni E; Trovò M; Tumolo S; Grigoletto E
Cancer; 1984 Aug; 54(3):393-6. PubMed ID: 6375853
[TBL] [Abstract][Full Text] [Related]
13. Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Giaccone G; Donadio M; Bonardi GM; Testore F; Calciati A
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):629-31. PubMed ID: 2838291
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of oral teniposide (VM-26).
Smit EF; Ousterhuis BE; Berendsen HH; Sleijfer DT; Postmus PE
Semin Oncol; 1992 Apr; 19(2 Suppl 6):35-9. PubMed ID: 1329226
[TBL] [Abstract][Full Text] [Related]
15. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
[TBL] [Abstract][Full Text] [Related]
16. A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
Tummarello D; Guidi F; Di Furia L; Gramazio A; Menichetti E; Cellerino R
J Chemother; 1989 Feb; 1(1):64-7. PubMed ID: 2542470
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of teniposide in advanced breast cancer.
Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
[TBL] [Abstract][Full Text] [Related]
18. Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.
Cox EB; Vogel CL; Carpenter JT; Raney M
Invest New Drugs; 1988 Apr; 6(1):37-9. PubMed ID: 3410666
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Radice PA; Bunn PA; Ihde DC
Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
[No Abstract] [Full Text] [Related]
20. Treatment of small cell bronchogenic carcinoma with VM-26.
Woods RL; Fox RM; Tattersall MH
Cancer Treat Rep; 1979; 63(11-12):2011-3. PubMed ID: 230897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
